Personal tools
Hancox RA, Allen MD, Holliday DL, Guttery DS, Edwards DR, Pennington CJ, Shaw JA, Walker RA, Pringle JH, Jones JL. Tumor-associated Tenascin-C isoforms promote breast cancer cell invasion and growth by MMP- independent mechanisms. Breast Cancer Res. 2009;11(2):R24.
Powerful pre-clinical platform for anti-cancer drug and biomarker discovery
Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development. Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform
---------------------------------
SEND Study Success
Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment. A nationwide first for this type of trial, using real-world data. The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper
---------------------------------
Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.
More information from Jenny McNair jm65@le.ac.uk
Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX
T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk
(Please note this email address should not be used for clinical referrals or patient correspondence)
Sat Nav users:
LE1 5WW
The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.
.
